SalioGen Therapeutics jobs and careers
Cambridge, MA, United States
About SalioGen Therapeutics
SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.
Founded in 2020 by Joseph Higgins.
- Founded
- 2020
- Employees
- 125
- Total funding
- $135M
- Headquarters
- Cambridge
Leadership
The top of SalioGen Therapeutics's org chart, with how many people report into each leader.
Joe Senn
SVP & Head of R&D
8 reports
Pat Sacco
SVP of Manufacturing, Quality & Operations
2 reports
Joseph J. Higgins
Member Board of Directors
Will Mcgown
Executive Director, Finance & FP&A
Jill Murray, PHR
Vice President Human Resources
LauraLee Hughes
Director, Corporate Development & Strategy
Michelle LeBlanc
Sr Director Of In Vivo Biology
3 reports
Timothy D. McKee
Associate Director Bioanalytical Development
1 report
Katherine O'Malley
Senior Program Manager
Oleg Iartchouk
Vice President, Biomarkers And Genomics
Sujit Jain
Sr Director, CMC Operations
Bryan Erwin
Associate Director, Facilities & Engineering
Board
Jesse B. Owens
Scientific Advisor
Thomas Quertermous
Scientific Advisor
Sean Stalfort
Director
John Maraganore
Advisor
Mark McClellan
Advisor
Beverly Davidson
Scientific Advisor
Jobs at SalioGen Therapeutics
No open positions right now. Explore more companies on TheJobsMap.